BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 20493842)

  • 41. Evaluation of immune responses in mice after DNA immunization with putative Toxoplasma gondii calcium-dependent protein kinase 5.
    Zhang NZ; Huang SY; Xu Y; Chen J; Wang JL; Tian WP; Zhu XQ
    Clin Vaccine Immunol; 2014 Jul; 21(7):924-9. PubMed ID: 24789795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Innate immunity to Toxoplasma gondii infection.
    Yarovinsky F
    Nat Rev Immunol; 2014 Feb; 14(2):109-21. PubMed ID: 24457485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective immunity against Toxoplasma gondii induced by DNA immunization with the gene encoding a novel vaccine candidate: calcium-dependent protein kinase 3.
    Zhang NZ; Huang SY; Zhou DH; Chen J; Xu Y; Tian WP; Lu J; Zhu XQ
    BMC Infect Dis; 2013 Oct; 13():512. PubMed ID: 24176018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucosal and systemic T cell response in mice intragastrically infected with Neospora caninum tachyzoites.
    Correia A; Ferreirinha P; Costa AA; Dias J; Melo J; Costa R; Ribeiro A; Faustino A; Teixeira L; Rocha A; Vilanova M
    Vet Res; 2013 Aug; 44(1):69. PubMed ID: 23937079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis.
    Novais FO; Carvalho LP; Graff JW; Beiting DP; Ruthel G; Roos DS; Betts MR; Goldschmidt MH; Wilson ME; de Oliveira CI; Scott P
    PLoS Pathog; 2013; 9(7):e1003504. PubMed ID: 23874205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-21 is required for optimal antibody production and T cell responses during chronic Toxoplasma gondii infection.
    Stumhofer JS; Silver JS; Hunter CA
    PLoS One; 2013; 8(5):e62889. PubMed ID: 23667536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective immune response in BALB/c mice induced by DNA vaccine of the ROP8 gene of Toxoplasma gondii.
    Parthasarathy S; Fong MY; Ramaswamy K; Lau YL
    Am J Trop Med Hyg; 2013 May; 88(5):883-7. PubMed ID: 23509124
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis.
    Santos Cda S; Boaventura V; Ribeiro Cardoso C; Tavares N; Lordelo MJ; Noronha A; Costa J; Borges VM; de Oliveira CI; Van Weyenbergh J; Barral A; Barral-Netto M; Brodskyn CI
    J Invest Dermatol; 2013 Jun; 133(6):1533-40. PubMed ID: 23321919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD8(+) T cells in leishmania infections: friends or foes?
    Stäger S; Rafati S
    Front Immunol; 2012; 3():5. PubMed ID: 22566891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toxoplasma on the brain: understanding host-pathogen interactions in chronic CNS infection.
    Kamerkar S; Davis PH
    J Parasitol Res; 2012; 2012():589295. PubMed ID: 22545203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autophagy is a cell death mechanism in Toxoplasma gondii.
    Ghosh D; Walton JL; Roepe PD; Sinai AP
    Cell Microbiol; 2012 Apr; 14(4):589-607. PubMed ID: 22212386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis.
    Passero LF; Carvalho AK; Bordon ML; Bonfim-Melo A; Toyama MH; Corbett CE; Laurenti MD
    Inflamm Res; 2012 Mar; 61(3):255-63. PubMed ID: 22166919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi.
    Nakayasu ES; Sobreira TJ; Torres R; Ganiko L; Oliveira PS; Marques AF; Almeida IC
    J Proteome Res; 2012 Jan; 11(1):237-46. PubMed ID: 22115061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The CD8 T-cell road to immunotherapy of toxoplasmosis.
    Bhadra R; Gigley JP; Khan IA
    Immunotherapy; 2011 Jun; 3(6):789-801. PubMed ID: 21668315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of CD8+ T cell responses to infection with parasitic protozoa.
    Jordan KA; Hunter CA
    Exp Parasitol; 2010 Nov; 126(3):318-25. PubMed ID: 20493842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines.
    Rodrigues MM; Boscardin SB; Vasconcelos JR; Hiyane MI; Salay G; Soares IS
    An Acad Bras Cienc; 2003 Dec; 75(4):443-68. PubMed ID: 14605680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunity to protozoa.
    Miller LH; Scott P
    Curr Opin Immunol; 1989-1990 Feb; 2(3):368-74. PubMed ID: 2699426
    [No Abstract]   [Full Text] [Related]  

  • 58. Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors.
    Gurung P; Kanneganti TD
    Cell Mol Life Sci; 2016 Aug; 73(16):3035-51. PubMed ID: 27032699
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.